{"id":879762,"date":"2025-08-27T16:28:23","date_gmt":"2025-08-27T20:28:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/"},"modified":"2025-08-27T16:28:23","modified_gmt":"2025-08-27T20:28:23","slug":"fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/","title":{"rendered":"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN FRANCISCO, Aug.  27, 2025  (GLOBE NEWSWIRE) &#8212; FibroGen, Inc.\u00a0(NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27<sup>th<\/sup>\u00a0Annual\u00a0Global Investment Conference\u00a0being held\u00a0September 8-10, 2025,\u00a0in\u00a0New York, NY.<\/p>\n<p>Thane Wettig, Chief Executive Officer of\u00a0FibroGen, will deliver a company presentation on\u00a0Tuesday, September 9\u00a0at\u00a012:00 PM ET\u00a0at the\u00a0Lotte New York Palace Hotel. A live webcast of the presentation will be available\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AS-74LusTHxb-JPLoknxIN8HsYRgoQZTviZ04g-wito1MLkd9kGIWOTmcxxXMIN3uBybEI_4VyjyVQ14GHE_vTZF8DAP-W2AFFJO9eWK9yhFoRzqHwUI86r_PVSlDRhGbpAl9n4nccy6nm3OYzVQ4w==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>FibroGen\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted, when available, to the\u00a0FibroGen\u00a0website on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8oZfilv6EnyoP4ktzk7VCzhjfcl7-8zWrl0KjltbMpSpr0NB9z8HX-S2VohrOvAAPOYCKveu5zA9TL9t6aSnUP103L8o3L_SMUU8pq-TZFgdvo13TZMdn-JYvoUP1hDy7-5iUU16_Br7sSUGsz6UVPJlfkENsJb7CXblEQTVdQ5MenUk0rk2-EI_1HWyl080jbfDxe9Whf4masI_Ln1-99nNUHRXvY0pHGUTAi28mSW3ry98s4PCXjv6X_SCrgh_yKUL0hJgvGmYAXSLuKt5g3fr9qrIad-skTlqNtiCSe6MKFzBqtXwoxiLa53c56NROdjUGo7RIVf8IC5TJYVArg==\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentation<\/a>\u00a0page of the Investors and Media section for 90 days.<\/p>\n<p>\n        <strong>About\u00a0FibroGen<\/strong><br \/>\n        <br \/>FibroGen, Inc.\u00a0is a biopharmaceutical company focused on development of novel therapies at the frontiers of cancer biology and anemia. Roxadustat (\u7231\u745e\u5353<sup>\u00ae<\/sup>, EVRENZO\u2122) is currently approved in\u00a0China,\u00a0Europe,\u00a0Japan, and numerous other countries for the treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis. The Company continues to evaluate a development plan for roxadustat in anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) in the\u00a0U.S.\u00a0FG-3246 (also known as FOR46), a first-in-class antibody-drug conjugate (ADC) targeting CD46 is in development for the treatment of metastatic castration-resistant prostate cancer. This program also includes the development of FG-3180, an associated CD46-targeted PET biomarker. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zbVUD5NrRDE4BvSM1QwL0mrLyAmmT7TWEfPq0KX5PPOHYTs5D5kR5ZMrqNpOLNcFl0Pngsoz5kBCdjgt---cDkahpMk3Vqi8_Sc9Tb_eQMtrFuBuZwXcy2jnwW5NLh9o4L0RLqkRURm6n1kE-R_-vCfuewGv0i0CDRgZ8huZ55YN4RBWrEhF9aw6JMgxApbdUmrBMQgneUc-4HpUKZC7uyUUyiGEB7XcKFPCMmvFKOlHvDqGY87f-jL6rFTnfUqZWKRfIV586GrD1ybc00CCWg==\" rel=\"nofollow\" target=\"_blank\">www.fibrogen.com<\/a>.<\/p>\n<p>\n        <strong>For Investor Inquiries:<\/strong><br \/>\n        <br \/>David DeLucia, CFA<br \/>Senior Vice President and Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1eQoha5tCYTRRgYvBhVOwAFjgJqLvVwbIJ_DE_ztoPGLFkf8uKbhuSIfA8W7GL06NJbbiCv6XjfD8yOFdWEF2A==\" rel=\"nofollow\" target=\"_blank\">ir@fibrogen.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzA2M2JlNDAtYzFkMi00MGY3LTkyNmItNWU1ZDkwYTBkYjJkLTEwMTk1MzYtMjAyNS0wOC0yNy1lbg==\/tiny\/FibroGen-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) &#8212; FibroGen, Inc.\u00a0(NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th\u00a0Annual\u00a0Global Investment Conference\u00a0being held\u00a0September 8-10, 2025,\u00a0in\u00a0New York, NY. Thane Wettig, Chief Executive Officer of\u00a0FibroGen, will deliver a company presentation on\u00a0Tuesday, September 9\u00a0at\u00a012:00 PM ET\u00a0at the\u00a0Lotte New York Palace Hotel. A live webcast of the presentation will be available\u00a0here. FibroGen\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted, when available, to the\u00a0FibroGen\u00a0website on the\u00a0Events &amp; Presentation\u00a0page of the Investors and Media section for 90 days. About\u00a0FibroGen FibroGen, Inc.\u00a0is a biopharmaceutical company focused on development of novel &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-879762","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) &#8212; FibroGen, Inc.\u00a0(NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th\u00a0Annual\u00a0Global Investment Conference\u00a0being held\u00a0September 8-10, 2025,\u00a0in\u00a0New York, NY. Thane Wettig, Chief Executive Officer of\u00a0FibroGen, will deliver a company presentation on\u00a0Tuesday, September 9\u00a0at\u00a012:00 PM ET\u00a0at the\u00a0Lotte New York Palace Hotel. A live webcast of the presentation will be available\u00a0here. FibroGen\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted, when available, to the\u00a0FibroGen\u00a0website on the\u00a0Events &amp; Presentation\u00a0page of the Investors and Media section for 90 days. About\u00a0FibroGen FibroGen, Inc.\u00a0is a biopharmaceutical company focused on development of novel &hellip; Continue reading &quot;FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-27T20:28:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference\",\"datePublished\":\"2025-08-27T20:28:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/\",\"name\":\"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=\",\"datePublished\":\"2025-08-27T20:28:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Market Newsdesk","og_description":"SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) &#8212; FibroGen, Inc.\u00a0(NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th\u00a0Annual\u00a0Global Investment Conference\u00a0being held\u00a0September 8-10, 2025,\u00a0in\u00a0New York, NY. Thane Wettig, Chief Executive Officer of\u00a0FibroGen, will deliver a company presentation on\u00a0Tuesday, September 9\u00a0at\u00a012:00 PM ET\u00a0at the\u00a0Lotte New York Palace Hotel. A live webcast of the presentation will be available\u00a0here. FibroGen\u2019s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted, when available, to the\u00a0FibroGen\u00a0website on the\u00a0Events &amp; Presentation\u00a0page of the Investors and Media section for 90 days. About\u00a0FibroGen FibroGen, Inc.\u00a0is a biopharmaceutical company focused on development of novel &hellip; Continue reading \"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-27T20:28:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference","datePublished":"2025-08-27T20:28:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/","name":"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=","datePublished":"2025-08-27T20:28:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxOTI0MSM3MTE4NjM4IzIwMDc5NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=879762"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/879762\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=879762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=879762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=879762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}